Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
1.225
+0.020 (1.66%)
Nov 2, 2026, 12:01 PM EST - Market open
Cellectar Biosciences Market Cap
Cellectar Biosciences has a market cap or net worth of $11.58 million as of November 2, 2026. It is the 40,662nd most valuable company in the world and the 5,510th biggest in the United States. Its market cap has increased by 7.21% in one year.
Market Cap
11.58M
Enterprise Value
-20.88M
1-Year Change
7.21%
Global Rank
Country Rank
#5,510 United States
Category
ChartMarket Cap Chart
Since August 15, 2014, Cellectar Biosciences's market cap has increased from $9.20M to $11.58M, an increase of 25.86%. That is a compound annual growth rate of 1.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 11.58M | -7.37% |
| Dec 31, 2025 | 12.50M | 1.63% |
| Dec 31, 2024 | 12.30M | -63.82% |
| Dec 29, 2023 | 34.00M | 112.50% |
| Dec 30, 2022 | 16.00M | -60.59% |
| Dec 31, 2021 | 40.60M | -27.24% |
| Dec 31, 2020 | 55.80M | 164.45% |
| Dec 31, 2019 | 21.10M | 185.14% |
| Dec 31, 2018 | 7.40M | -65.90% |
| Dec 29, 2017 | 21.70M | 233.85% |
| Dec 30, 2016 | 6.50M | 3.17% |
| Dec 31, 2015 | 6.30M | -73.08% |
| Dec 31, 2014 | 23.40M | 154.35% |
| Aug 15, 2014 | 9.20M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pasithea Therapeutics | 12.37M |
| aTyr Pharma | 12.11M |
| Lipocine | 11.87M |
| TScan Therapeutics | 11.83M |
| SeaStar Medical Holding | 11.78M |
| Purple Biotech | 11.25M |
| Passage Bio | 11.10M |
| Intensity Therapeutics | 11.10M |